Core Insights - PetVivo Animal Health, Inc. has entered into a Vendor Partner Agreement with Veterinary Growth Partners to promote its innovative veterinary products [1][5] - The agreement aims to enhance the accessibility and adoption of PetVivo's flagship products, Spryng with OsteoCushion Technology and PrecisePRP, among veterinary practices [2][5] Company Overview - PetVivo Holdings, Inc. is focused on the commercialization of biomedical devices and therapeutics for companion animals, leveraging human therapies for efficient treatment solutions [6][7] - The company has a robust pipeline of products protected by twelve patents and six trade secrets, including Spryng and PrecisePRP [7] Product Details - Spryng with OsteoCushion Technology is an intra-articular injectable device designed to manage joint pain and improve joint mechanics in animals [3] - PrecisePRP is a first-in-class, off-the-shelf platelet-rich plasma product that provides a consistent dose of 4 billion platelets per vial, designed for easy use by veterinarians [4] Partnership Impact - The collaboration with Veterinary Growth Partners is expected to expand national availability and enhance purchasing efficiency for veterinary practices seeking non-pharmaceutical solutions [5][8] - Veterinary Growth Partners supports over 7,300 veterinary members across the U.S., providing a significant network for PetVivo's products [1][2]